245 related articles for article (PubMed ID: 18478486)
21. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
Novitzky N; Thomas V; du Toit C; McDonald A
Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315
[TBL] [Abstract][Full Text] [Related]
22. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
Boulad F; Gillio A; Small TN; George D; Prasad V; Torok-Castanza J; Regan AD; Collins N; Auerbach AD; Kernan NA; O'Reilly RJ
Br J Haematol; 2000 Dec; 111(4):1153-7. PubMed ID: 11167755
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
24. Haematopoeitic cell transplantation for Fanconi anaemia - when and how?
MacMillan ML; Wagner JE
Br J Haematol; 2010 Apr; 149(1):14-21. PubMed ID: 20136826
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children.
Liu D; Huang X; Liu K; Xu L; Chen H; Han W; Chen Y; Zhang X; Jiang Q
Biol Blood Marrow Transplant; 2008 Apr; 14(4):469-77. PubMed ID: 18342790
[TBL] [Abstract][Full Text] [Related]
26. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
[TBL] [Abstract][Full Text] [Related]
28. Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning.
Ayas M; Al-Jefri A; Al-Seraihi A; Al-Mahr M; Al-Ahmari A; El-Solh H
Biol Blood Marrow Transplant; 2008 Apr; 14(4):445-8. PubMed ID: 18342787
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning.
Medeiros C; Zanis-Neto J; Pasquini R
Bone Marrow Transplant; 1999 Oct; 24(8):849-52. PubMed ID: 10516695
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience.
Ayas M; Al-Jefri A; Al-Seraihi A; Al-Mahr M; Rifai S; Al-Ahmari A; Khairy A; El-Hassan I; El-Solh H
Bone Marrow Transplant; 2008 Feb; 41(3):261-5. PubMed ID: 17982499
[TBL] [Abstract][Full Text] [Related]
31. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
Thakar MS; Bonfim C; Sandmaier BM; O'Donnell P; Ribeiro L; Gooley T; Deeg HJ; Flowers ME; Pasquini R; Storb R; Woolfrey AE; Kiem HP
Pediatr Hematol Oncol; 2012 Sep; 29(6):568-78. PubMed ID: 22839094
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
[TBL] [Abstract][Full Text] [Related]
33. Related donor hematopoietic stem cell transplantation for Fanconi anemia without radiation: a single center experience in Turkey.
Ertem M; Ileri T; Azik F; Uysal Z; Gozdasoglu S
Pediatr Transplant; 2009 Feb; 13(1):88-95. PubMed ID: 18433407
[TBL] [Abstract][Full Text] [Related]
34. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
35. Delayed engraftment and mixed chimerism after HLA-identical sibling donor BMT in Fanconi anaemia.
Mital MK; Curtis A; Spencer V; Barge D; Skinner R
Bone Marrow Transplant; 1999 Jul; 24(2):201-4. PubMed ID: 10455350
[TBL] [Abstract][Full Text] [Related]
36. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
[TBL] [Abstract][Full Text] [Related]
37. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
[TBL] [Abstract][Full Text] [Related]
39. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
40. Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.
Thakar MS; Bonfim C; Walters MC; Storb R; Pasquini R; Burroughs L; Sandmaier BM; Woolfrey A; Kiem HP
Bone Marrow Transplant; 2017 Apr; 52(4):570-573. PubMed ID: 28067886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
